Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis
Status:
Completed
Trial end date:
2003-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to compare the pharmacodynamics of intravenous (IV)
lansoprazole to oral lansoprazole capsules, once daily (QD), in participants with erosive
esophagitis.